CVS Health Co. (NYSE:CVS – Get Free Report) was the recipient of a significant growth in short interest during the month of June. As of June 15th, there was short interest totalling 20,640,000 shares, a growth of 16.5% from the May 31st total of 17,710,000 shares. Based on an average daily volume of 12,590,000 shares, the short-interest ratio is presently 1.6 days. Approximately 1.7% of the company’s shares are short sold.
CVS Health Trading Up 1.2 %
CVS Health stock opened at $59.06 on Monday. CVS Health has a 1 year low of $52.77 and a 1 year high of $83.25. The company has a market cap of $74.14 billion, a P/E ratio of 10.38, a PEG ratio of 0.56 and a beta of 0.53. The company has a debt-to-equity ratio of 0.78, a quick ratio of 0.61 and a current ratio of 0.81. The firm’s 50-day moving average is $59.56 and its 200-day moving average is $70.13.
CVS Health (NYSE:CVS – Get Free Report) last released its quarterly earnings data on Wednesday, May 1st. The pharmacy operator reported $1.31 earnings per share for the quarter, missing analysts’ consensus estimates of $1.69 by ($0.38). CVS Health had a return on equity of 13.53% and a net margin of 2.03%. The firm had revenue of $88.44 billion during the quarter, compared to analyst estimates of $89.33 billion. During the same period last year, the business earned $2.20 EPS. The firm’s revenue was up 3.7% on a year-over-year basis. On average, equities analysts expect that CVS Health will post 7.02 earnings per share for the current year.
Analyst Ratings Changes
Get Our Latest Analysis on CVS
Insider Buying and Selling
In related news, Director Edward J. Ludwig purchased 1,000 shares of the firm’s stock in a transaction on Thursday, May 2nd. The shares were bought at an average price of $53.88 per share, for a total transaction of $53,880.00. Following the acquisition, the director now directly owns 21,630 shares in the company, valued at $1,165,424.40. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. 0.24% of the stock is currently owned by company insiders.
Institutional Trading of CVS Health
A number of hedge funds and other institutional investors have recently made changes to their positions in CVS. SOA Wealth Advisors LLC. increased its stake in CVS Health by 4.9% in the 4th quarter. SOA Wealth Advisors LLC. now owns 2,859 shares of the pharmacy operator’s stock worth $226,000 after purchasing an additional 133 shares in the last quarter. Apella Capital LLC raised its holdings in shares of CVS Health by 4.2% during the fourth quarter. Apella Capital LLC now owns 3,378 shares of the pharmacy operator’s stock valued at $272,000 after acquiring an additional 136 shares during the period. Prairie Sky Financial Group LLC lifted its position in shares of CVS Health by 4.1% in the 4th quarter. Prairie Sky Financial Group LLC now owns 3,612 shares of the pharmacy operator’s stock valued at $285,000 after acquiring an additional 141 shares in the last quarter. WealthShield Partners LLC boosted its stake in CVS Health by 3.2% in the 4th quarter. WealthShield Partners LLC now owns 4,498 shares of the pharmacy operator’s stock worth $355,000 after purchasing an additional 141 shares during the period. Finally, Sugarloaf Wealth Management LLC grew its position in CVS Health by 9.5% during the 4th quarter. Sugarloaf Wealth Management LLC now owns 1,639 shares of the pharmacy operator’s stock worth $129,000 after purchasing an additional 142 shares in the last quarter. 80.66% of the stock is currently owned by institutional investors.
CVS Health Company Profile
CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.
Featured Stories
- Five stocks we like better than CVS Health
- How to invest in marijuana stocks in 7 steps
- Upwork Stock’s Outlook: Numbers Solid Despite Gen-AI Challenges
- How to Invest in Small Cap Stocks
- What’s Behind Walgreens Stock Plunge: What Investors Can Do Next
- How to Know if a Stock Pays Dividends and When They Are Paid Out
- MarketBeat Week in Review – 6/24 – 6/28
Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.